A clinical discussion calls for clearer menopause mental-health referrals, with context on symptom assessment, therapy survey findings and ACOG guidance.
On October 29, 2026, Chief Healthcare Executive published a clinical discussion with Dr. Kristin MacGregor of LifeStance Health about menopause-related mental health and access to support. MacGregor, the organisation’s national clinical director for integrated behavioral health, urged health systems to connect questions about distress with straightforward referrals and follow-up care.
The discussion challenges a gap in care rather than overturning a medical consensus. In MacGregor’s account, women can face an expectation to manage midlife emotional difficulties alone while navigating menopause alongside work and caregiving.
Her proposal shifts attention from whether women mention symptoms to what healthcare services do with that information. Recognition matters, but asking about anxiety or low mood is only the beginning. The update she advocates is organisational: mental-health conversations should have a clear route into support rather than ending with an unanswered concern.
Chief Healthcare Executive reported several findings from a LifeStance Health survey that connect awareness of symptoms with experiences of seeking care:
The article does not provide the survey’s sample size or field dates. It also gives limited information about respondent characteristics. These are LifeStance survey findings rather than population-wide prevalence estimates, and reported helpfulness is not proof of a treatment’s effect.
Read within those limits, the findings make a case for clearer information. Women need language for discussing what has changed and an understandable account of the support available. The survey also gives health services a reason to explain what mental-health care may involve rather than assuming patients already know.
In Contemporary OB/GYN, Jean Cunningham recommends assessing symptoms through their timing and wider context. Her approach avoids treating midlife distress as either exclusively hormonal or exclusively psychological.
Anxiety and irritability can warrant attention alongside low mood. Concentration problems and disrupted sleep also belong in the conversation. These symptoms do not establish a mental-health diagnosis or prove that hormones are the cause.
The assessment Cunningham describes brings several kinds of information together:
For a reader preparing to speak with a clinician, the useful starting point is what has changed and how it affects daily life. Describing the pattern gives the clinician more to work with than deciding in advance that the problem must be menopause or must be unrelated to it.
This is also why the conversation should leave room for more than a symptom label. A discussion about sleep or difficulty coping can sit alongside questions about menstrual changes and health history. Refemina’s coverage of assessment that includes emotional health offers related context for that conversation.
MacGregor’s central recommendation is that screening should lead somewhere. She argues for questions about mental health to be paired with referral routes that are easy for both clinicians and patients to navigate.
This is a practical health-system proposal, not a specific validated screening protocol. Its focus is the connection between recognising a concern and making support reachable.
For readers, that translates into several reasonable questions during a clinical conversation:
These questions do not require a woman to choose her own treatment. They clarify what the care team will do next and where responsibility for follow-through sits.
There is a meaningful difference between being asked about distress and leaving with an understandable next step. MacGregor’s recommendation puts that connection within the care pathway rather than leaving a woman to interpret a screening response alone.
For health services, the practical test is therefore not only whether the question was asked. It is whether the response reaches someone who can assess it and help arrange the next conversation. A referral should function as a connection to care rather than another task with no clear destination.
MacGregor described integrated behavioral-health clinicians within primary care as a useful option where health systems have the resources. In that model, mental-health support can sit closer to the setting where other midlife concerns are discussed.
She also described different advantages of remote and in-person appointments. Telehealth can help women managing family responsibilities. An appointment away from home may offer privacy or time free from household interruptions.
The useful comparison is therefore practical rather than a claim that one format is best. Scheduling and privacy deserve a place in a referral conversation alongside the type of support being offered.
MacGregor’s observations also keep the wider midlife picture in view. A woman may be navigating menopause while caring for others and meeting work demands. In her account, access needs to reflect those circumstances rather than assuming that receiving a referral makes attending care straightforward.
On October 15, 2026, ACOG announced expanded clinical guidance addressing menopause-related symptoms that include sleep and mood. The announcement also covers treatment options and patient education.
Its position on depressive symptoms is specific: evidence is insufficient to recommend for or against menopausal hormone therapy specifically for menopause-related depressive symptoms. For patients who meet criteria for major depressive disorder, or whose predominant symptom is depression, ACOG advises care according to depression-management guidance.
That distinction matters when discussing possible support. Recognising that menopause may be relevant to someone’s experience is a different question from choosing a treatment for depression.
The broader ACOG announcement discusses hormonal and nonhormonal options. It also includes cognitive behavioral therapy and other nonpharmacologic approaches within menopause symptom management. That range should be read as guidance covering different clinical needs rather than a prescription for every woman with low mood.
Personal decisions belong with qualified clinicians who can assess the presenting problem. The useful discussion is about which symptoms need care and which options fit that assessment. For readers whose concerns include disrupted nights, Refemina also examines sleep during the menopausal transition.
MacGregor said that mental-health challenges associated with perimenopause and menopause can go “above and beyond” ordinary adjustment to life changes for some women. She also challenged the expectation that women should simply “power through.”
Those comments are her clinical perspective. They bring attention to distress that may otherwise be treated as a private test of endurance.
In the discussion, MacGregor described therapy as potentially useful for developing coping skills and setting boundaries. She also spoke about making room for personal needs. The case for access is about making support available rather than prescribing therapy to every woman.
For women whose emotional changes have unsettled their confidence, this framing leaves room for help without turning the experience into a character judgement. Naming difficulty coping is a way to begin a care conversation, not an admission of personal failure.
It also leaves room for the person beyond the symptoms. Questions about identity and relationships remain legitimate parts of midlife health. Refemina’s discussion of feeling different in yourself during perimenopause considers that wider experience without making hormones the only explanation.
The direction for clinical practice should be clearer recognition of emotional distress linked to contextual assessment and dependable follow-up, rather than another screening question without a route to care.
Midlife emotional changes call for discussion with healthcare professionals when care is needed; Refemina takes on the information question through research-led writing about confidence and reinvention. Readers facing uncertainty about who they are becoming can find explanations that place physical change alongside personal experience, free from youth-focused messaging or supplement promotion.
Follow Refemina for research-led insights on menopause, strength, metabolism, nutrition, skin, intimacy and confidence through midlife. New articles turn complex topics into clear, useful context.
Keep learning about the changes that shape energy, strength, confidence and wellbeing through midlife.
Explore Resources